Ads
related to: Novavax Vaccine- How RSV Spreads
Learn About RSV Symptoms.
Visit the Patient Website.
- RSV Product Option
Visit the Patient Site Today.
Learn About an RSV Product Option.
- Stay in the Loop
Sign-Up to Stay in the Loop.
Receive Updates and News.
- Share the News
Share the News Today!
Visit the Patient Website.
- How RSV Spreads
Search results
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 6 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 7 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 7 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 6 days agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 6 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 3 days agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 6 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher than the ...
Novavax (NASDAQ:NVAX) PT Raised to $18.00
ETF DAILY NEWS· 4 days agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price increased by Bank of America from $12.00 to $18.00 in a research report issued to clients and investors on Friday ...
Ad
related to: Novavax Vaccine